Orchid Pharma Limited (IN:ORCHPHARMA)
:ORCHPHARMA
Want to see IN:ORCHPHARMA full AI Analyst Report?
Total Valuation
Orchid Pharma Limited has a market cap or net worth of ₹48.72B. The enterprise value is ₹56.72B.
Market Cap₹48.72B
Enterprise Value₹56.72B
Share Statistics
Orchid Pharma Limited has 50,719,105 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding50,719,105
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Orchid Pharma Limited’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 0.34%.
Return on Equity (ROE)0.02
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)0.34%
Return on Capital Employed (ROCE)<0.01
Revenue Per Employee9.31M
Profits Per Employee235.90K
Employee Count871
Asset Turnover0.42
Inventory Turnover2.55
Valuation Ratios
The current PE Ratio of Orchid Pharma Limited is 261.1. Orchid Pharma Limited’s PEG ratio is -1.50.
PE Ratio261.1
PS Ratio3.02
PB Ratio1.90
Price to Fair Value1.90
Price to FCF-8.94
Price to Operating Cash Flow461.75
PEG Ratio-1.50
Income Statement
In the last 12 months, Orchid Pharma Limited had revenue of 8.11B and earned 205.47M in profits. Earnings per share was 4.05.
Revenue8.11B
Gross Profit1.59B
Operating Income56.76M
Pretax Income203.55M
Net Income205.47M
EBITDA411.28M
Earnings Per Share (EPS)4.05
Cash Flow
In the last 12 months, operating cash flow was 115.10M and capital expenditures -1.59B, giving a free cash flow of -1.47B billion.
Operating Cash Flow115.10M
Free Cash Flow-1.47B
Free Cash Flow per Share-29.03
Dividends & Yields
Orchid Pharma Limited pays an annual dividend of ₹3, resulting in a dividend yield of ―
Dividend Per Share₹3
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.24
52-Week Price Change48.76%
50-Day Moving Average679.96
200-Day Moving Average711.24
Relative Strength Index (RSI)86.50
Average Volume (3m)10.21K
Important Dates
Orchid Pharma Limited upcoming earnings date is Aug 6, 2026, TBA (Confirmed).
Last Earnings DateMay 25, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Orchid Pharma Limited as a current ratio of 2.45, with Debt / Equity ratio of 28.16%
Current Ratio2.45
Quick Ratio1.53
Debt to Market Cap0.15
Net Debt to EBITDA8.65
Interest Coverage Ratio0.43
Taxes
In the past 12 months, Orchid Pharma Limited has paid -1.92M in taxes.
Income Tax-1.92M
Effective Tax Rate>-0.01
Enterprise Valuation
Orchid Pharma Limited EV to EBITDA ratio is 68.16, with an EV/FCF ratio of -10.24.
EV to Sales3.46
EV to EBITDA68.16
EV to Free Cash Flow-10.24
EV to Operating Cash Flow25.51
Balance Sheet
Orchid Pharma Limited has ₹1.50B in cash and marketable securities with ₹2.82B in debt, giving a net cash position of -₹1.32B billion.
Cash & Marketable Securities₹1.50B
Total Debt₹2.82B
Net Cash-₹1.32B
Net Cash Per Share-₹26.03
Tangible Book Value Per Share₹239.31
Margins
Gross margin is 31.52%, with operating margin of 0.70%, and net profit margin of 2.53%.
Gross Margin31.52%
Operating Margin0.70%
Pretax Margin2.51%
Net Profit Margin2.53%
EBITDA Margin5.07%
EBIT Margin0.70%
Analyst Forecast
The average price target for Orchid Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-12.00%
EPS Growth Forecast-79.57%